International Journal of Drug Policy
Volume 21, Issue 1 , Pages 77-81 , January 2010

“They’re legal so they’re safe, right?” What did the legal status of BZP-party pills mean to young people in New Zealand?

Received 30 October 2008 ,Revised 4 February 2009 ,Accepted 11 February 2009.

References 

  1. Amonini C, Donovan R. The relationship between youth's moral and legal perceptions of alcohol, tobacco and marijuana and use of these substances. Health Education Research. 2006;21(2):276–286
  2. Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’). Neuropsychopharmacology. 2005;30(3):550–560
  3. Campbell H, Cline W, Evans M, Lloyd J, Peck AW. Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. European Journal of Clinical Pharmacology. 1973;6(3):170–176
  4. Menghrajani P, Klaue K, Dubois-Arber F, Michaud PA. Swiss adolescents’ and adults’ perceptions of cannabis use: A qualitative study. Health Education Research. 2005;20(4):476–484
  5. Ministry of Health . Report prepared for the 46th Session of the Commission on Narcotic Drugs, Vienna. Wellington: Ministry of Health; 2003;
  6. Nicholson TC. Prevalence of use, epidemiology and toxicity of ‘herbal party pills’ among those presenting to the emergency department. Emergency Medicine Australasia. 2006;18(2):180–184
  7. Ogilvie D, Gruer L, Haw S. Young people's access to tobacco, alcohol, and other drugs. British Medical Journal. 2005;331:393–396
  8. Thomas D. A general inductive approach for qualitative analysis. Auckland: The University of Auckland; 2003;
  9. Wilkins C, Girling M, Sweetsur P. The prevalence of use, dependency and harms of legal party pills containing benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) in New Zealand. Journal of Substance Use. 2007;12(3):213–224
  10. Wilkins C, Rose E. The socio-economic impact of amphetamine type stimulants (ATS) in New Zealand. Part 1. Level of use and health harms. Auckland: Massey University; 2004;

PII: S0955-3959(09)00045-0

doi: 10.1016/j.drugpo.2009.02.002

International Journal of Drug Policy
Volume 21, Issue 1 , Pages 77-81 , January 2010

Article Tools